CA
TENX icon

Commerzbank Aktiengesellschaft’s Tenax Therapeutics TENX Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-3
Closed -$195K – 982
2016
Q4 		$195K Sell
3
-3
-50% -$176K ﹤0.01% 908
2016
Q3 		$463K Sell
6
-3
-33% -$237K 0.01% 590
2016
Q2 		$768 Hold
9
– – 0.01% 538
2016
Q1 		$615K Hold
9
– – 0.01% 625
2015
Q4 		$984K Sell
9
-14
-61% -$1.45M 0.01% 656
2015
Q3 		$2.22M Buy
+23
New +$2.63M 0.02% 417

Other funds holding TENX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Commerzbank Aktiengesellschaft's TENX Position: Q1 2017 in Review

Commerzbank Aktiengesellschaft sold out of Tenax Therapeutics (TENX) in Q1 2017, closing a stake of 3 shares — an estimated $195K sold.

Commerzbank Aktiengesellschaft first reported a position in TENX in Q3 2015 and held it in 6 quarters. The position peaked at $2.22M in Q3 2015. 11 funds tracked by Wall St. Rank hold TENX as of Q1 2017.

  • Commerzbank Aktiengesellschaft reported no remaining Tenax Therapeutics position as of Q1 2017 after selling out during the quarter.
  • Commerzbank Aktiengesellschaft sold 3 Tenax Therapeutics shares in Q1 2017, an estimated $195K.
  • Commerzbank Aktiengesellschaft first reported a position in Tenax Therapeutics in Q3 2015 and held it in 6 quarters.
  • Commerzbank Aktiengesellschaft's Tenax Therapeutics position peaked at $2.22M in Q3 2015.
  • 11 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2017.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2017, filed 1 May 2017.